Investment Rating - The report maintains a "Buy" rating for the company [2] Core Insights - The company achieved a revenue of 450 million and a net profit of 327 million in the first half of 2025, reflecting a year-on-year growth of 25.64% and a turnaround from losses, with adjusted net profit increasing by 126.1% [5] - The company's gross margin and net margin for H1 2025 were 37.62% and 72.72%, respectively, showing improvements of 3.59 percentage points and 206.85 percentage points year-on-year [5] - The company has expanded its store network significantly, with a total of 113 stores globally as of June 30, 2025, including 31 self-operated and 53 managed postpartum centers [6] - The postpartum recovery and family care business segments are experiencing rapid growth, with self-operated centers generating 387 million in revenue, up 25.3% year-on-year, and managed centers achieving 73 million, a 159.6% increase [6] - The company is also expanding its overseas presence, having opened its first store in New York post-IPO, with plans for further international expansion [6] Financial Summary - The company forecasts revenues of 1.076 billion, 1.403 billion, and 1.777 billion for 2025, 2026, and 2027, respectively, representing year-on-year growth rates of 34.73%, 30.42%, and 26.65% [9] - The projected net profit for the same years is 315 million, 406 million, and 478 million, with growth rates of 157.65%, 28.75%, and 17.71% [9] - Adjusted net profit estimates for 2025, 2026, and 2027 are 122 million, 197 million, and 267 million, reflecting substantial growth of 189.63%, 61.58%, and 35.69% [9]